Similar articles

• The role of alpha 1-blockers in combination therapy for hypertension.

  Zusman RM. Zusman RM. Int J Clin Pract. 2000 Jan-Feb;54(1):36-40. Int J Clin Pract. 2000. PMID: 10750258 Review.
• Blood pressure and lipid lowering effects of terazosin.

  Rosenthal J. Rosenthal J. J Hum Hypertens. 1989 Dec;3 Suppl 2:85-9; discussion 90-1. J Hum Hypertens. 1989. PMID: 2575179 Review.
• Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.

  Talseth T, Westlie L, Daae LN. Talseth T, et al. J Hypertens Suppl. 1990 Sep;8(5):S47-51. J Hypertens Suppl. 1990. PMID: 1981077 Clinical Trial.
• Orthostatic hypotension: how to avoid it during antihypertensive therapy.

  Rieckert H. Rieckert H. Am J Hypertens. 1996 Nov;9(11):155S-159S. doi: 10.1016/0895-7061(96)00291-9. Am J Hypertens. 1996. PMID: 8931848 Clinical Trial.
• Clinical settings for selective alpha-adrenergic receptor inhibition: rationale and management strategies. Proceedings of a symposium. Naples, Florida, October 13 to 16, 1988.

  [No authors listed] [No authors listed] Am J Med. 1989 Aug 16;87(2A):1S-66S. Am J Med. 1989. PMID: 2569821 No abstract available.